Literature DB >> 12079610

Nickel-induced plasma lipid peroxidation and effect of antioxidants in human blood: involvement hydroxyl radical formation and depletion of alpha-tocopherol.

Chang-Yu Chen1, Yuh-Juan Su, Pey-Fen Wu, Mei-Miin Shyu.   

Abstract

To provide evidence for the oxidative effect of nickel (Ni) treatment on blood, lipid peroxidation (LPO) and hydroxyl radical (*OH) generation were examined in human plasma. Nickel chloride induced LPO in plasma of human blood in vitro in a concentration-dependent (0-10 mM) and time-dependent (0-2 h) manner. The *OH production in plasma was quantified by measurement of conversion of salicylic acid (SA) into its hydroxylated products, 2,3- and 2,5-dihydroxybenzoate (DHB). The concentrations of 2,3- and 2,5-DHB in plasma increased in a concentration-dependent manner after Ni treatment for 1 h. Furthermore, a decreasing trend in alpha-tocopherol levels in plasma was observed after Ni treatment. Concurrent incubation with gluthathione (GSH), catechin (CTCH), and mannitol decreased lipid peroxidation and reduced *OH formation induced by Ni, but exacerbation of the decrease of alpha-tocopherol in plasma occurred with catechin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12079610     DOI: 10.1080/00984100290071162

Source DB:  PubMed          Journal:  J Toxicol Environ Health A        ISSN: 0098-4108


  3 in total

1.  The influence of natural stressors on the toxicity of nickel to Daphnia magna.

Authors:  Abel L G Ferreira; Pedro Serra; Amadeu M V M Soares; Susana Loureiro
Journal:  Environ Sci Pollut Res Int       Date:  2010-02-20       Impact factor: 4.223

2.  Mannitol prevents acute lung injury after pancreas ischemia-reperfusion: a dose-response, ex vivo study.

Authors:  Avi A Weinbroum
Journal:  Lung       Date:  2009-06-17       Impact factor: 2.584

3.  Molecular and genomic approach for understanding the gene-environment interaction between Nrf2 deficiency and carcinogenic nickel-induced DNA damage.

Authors:  Hye Lim Kim; Young Rok Seo
Journal:  Oncol Rep       Date:  2012-09-26       Impact factor: 3.906

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.